bf/NASDAQ:GBT_icon.jpeg

NASDAQ:GBT

Global Blood Therapeutics, Inc.

  • Stock

USD

Last Close

68.48

04/10 20:00

Volume Today

3.28M

Avg: -

PE Ratio

−27.41

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
revenue
2.11M
-
123.80M
5,773.01%
194.75M
57.31%
cost of revenue
48K
-
1.99M
4,037.50%
3.32M
66.97%
gross profit
2.06M
-
121.82M
5,813.45%
191.43M
57.15%
selling and marketing expenses
general and administrative expenses
2.31M
-
3.85M
66.96%
9.67M
150.87%
21.91M
126.61%
31.44M
43.45%
51.44M
63.61%
117.09M
127.64%
selling general and administrative expenses
2.31M
-
3.85M
66.96%
9.67M
150.87%
21.91M
126.61%
31.44M
43.45%
51.44M
63.61%
117.09M
127.64%
210.85M
80.08%
266.99M
26.62%
research and development expenses
12.86M
-
16.32M
26.99%
36.66M
124.56%
61.21M
66.99%
87.81M
43.45%
131.31M
49.54%
174.56M
32.94%
155.12M
11.13%
212.13M
36.75%
other expenses
65K
-
210.85M
-
cost and expenses
15.66M
-
20.51M
30.95%
46.39M
126.19%
83.13M
79.18%
119.25M
43.45%
182.74M
53.25%
291.69M
59.62%
367.96M
26.15%
482.44M
31.11%
operating expenses
15.16M
-
20.18M
33.07%
46.39M
129.91%
83.13M
79.18%
119.25M
43.45%
182.74M
53.25%
291.64M
59.59%
365.97M
25.49%
479.12M
30.92%
interest expense
9.81M
-
15.47M
57.68%
ebitda
-17.58M
-
-20.14M
14.55%
-45.49M
125.84%
-81.23M
78.59%
-115.37M
42.02%
-169.59M
47.00%
-256.83M
51.45%
-226.92M
11.65%
-278.53M
22.74%
operating income
-15.66M
-
-20.51M
30.95%
-46.39M
126.19%
-83.13M
79.18%
-119.25M
43.45%
-182.74M
53.25%
-281.28M
53.92%
-243.17M
13.55%
-287.15M
18.08%
depreciation and amortization
534K
-
666K
24.72%
873K
31.08%
1.24M
41.47%
1.66M
34.25%
4.61M
177.86%
9.93M
115.58%
10.82M
8.97%
8.62M
20.39%
total other income expenses net
-2.45M
-
-296K
87.93%
33K
111.15%
659K
1,896.97%
2.22M
237.03%
8.55M
284.92%
14.52M
69.81%
-4.38M
130.18%
-15.47M
253.05%
income before tax
-18.12M
-
-20.81M
14.85%
-46.36M
122.81%
-82.47M
77.89%
-117.02M
41.90%
-174.19M
48.85%
-266.77M
53.14%
-247.55M
7.20%
-302.61M
22.24%
income tax expense
-2.45M
-
-296K
87.93%
33K
111.15%
659K
1,896.97%
2.22M
237.03%
8.55M
284.92%
14.52M
69.81%
5.43M
62.61%
477K
91.21%
net income
-18.12M
-
-20.81M
14.85%
-46.36M
122.81%
-82.47M
77.89%
-117.02M
41.90%
-174.19M
48.85%
-266.77M
53.14%
-247.55M
7.20%
-303.09M
22.43%
weighted average shs out
21.80M
-
13.76M
36.87%
12.81M
6.94%
33.21M
159.30%
42.32M
27.45%
51.15M
20.86%
58.32M
14.02%
61.33M
5.17%
62.93M
2.59%
weighted average shs out dil
21.80M
-
13.76M
36.87%
12.81M
6.94%
33.21M
159.30%
42.32M
27.45%
51.15M
20.86%
58.32M
14.02%
61.33M
5.17%
62.93M
2.59%
eps
-0.83
-
-1.51
81.93%
-3.62
139.74%
-2.48
31.49%
-2.76
11.29%
-3.41
23.55%
-4.57
34.02%
-4.04
11.60%
-4.82
19.31%
epsdiluted
-0.83
-
-1.51
81.93%
-3.62
139.74%
-2.48
31.49%
-2.76
11.29%
-3.41
23.55%
-4.57
34.02%
-4.04
11.60%
-4.82
19.31%

All numbers in USD (except ratios and percentages)